Y Intercept Hong Kong Ltd lowered its stake in shares of Genpact Limited (NYSE:G – Free Report) by 29.3% in the third quarter, Holdings Channel reports. The firm owned 116,471 shares of the business services provider’s stock after selling 48,337 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Genpact were worth $4,879,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Wealth Enhancement Advisory Services LLC boosted its holdings in Genpact by 2.5% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 9,890 shares of the business services provider’s stock valued at $454,000 after acquiring an additional 240 shares during the period. JLB & Associates Inc. lifted its position in shares of Genpact by 0.8% during the 3rd quarter. JLB & Associates Inc. now owns 37,646 shares of the business services provider’s stock worth $1,577,000 after purchasing an additional 292 shares during the last quarter. Global X Japan Co. Ltd. boosted its stake in Genpact by 33.0% during the 3rd quarter. Global X Japan Co. Ltd. now owns 1,190 shares of the business services provider’s stock valued at $50,000 after purchasing an additional 295 shares during the period. Louisiana State Employees Retirement System grew its holdings in Genpact by 0.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 45,300 shares of the business services provider’s stock valued at $1,994,000 after buying an additional 300 shares during the last quarter. Finally, Main Management ETF Advisors LLC boosted its position in shares of Genpact by 1.7% in the second quarter. Main Management ETF Advisors LLC now owns 20,524 shares of the business services provider’s stock valued at $903,000 after acquiring an additional 336 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Stock Performance
NYSE G opened at $45.82 on Monday. The firm has a market cap of $7.90 billion, a price-to-earnings ratio of 14.78, a PEG ratio of 1.36 and a beta of 0.75. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 0.33. Genpact Limited has a 1-year low of $37.49 and a 1-year high of $56.76. The company has a 50 day moving average of $46.25 and a 200-day moving average of $43.92.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on G. Wall Street Zen raised shares of Genpact from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Susquehanna started coverage on shares of Genpact in a research report on Friday, December 12th. They set a “neutral” rating and a $50.00 price objective for the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Genpact in a research report on Friday, December 26th. Finally, Citigroup upgraded Genpact to a “hold” rating in a research report on Thursday, October 23rd. Two equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $50.50.
Read Our Latest Stock Analysis on G
Insider Activity at Genpact
In other news, SVP Riju Vashisht sold 16,016 shares of the stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total transaction of $747,146.40. Following the sale, the senior vice president directly owned 95,521 shares of the company’s stock, valued at $4,456,054.65. This represents a 14.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Tamara Franklin sold 2,750 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $45.65, for a total value of $125,537.50. Following the completion of the transaction, the director owned 22,236 shares in the company, valued at $1,015,073.40. The trade was a 11.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 60,385 shares of company stock valued at $2,762,475 over the last ninety days. 2.80% of the stock is owned by insiders.
Genpact Profile
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
See Also
- Five stocks we like better than Genpact
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- Buy This Stock at 9:30 AM on MONDAY!
- What Expenses Can Be Deducted From Capital Gains Tax?
- A U.S. “birthright” claim worth trillions – activated quietly
- Trump just signed it
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
